Inactive Instrument

InterMune Inc Stock

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

17/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE

17/09/14	CHUGAI PHARMACEUTICAL : Roche's $8 billion InterMune buy not a signal for more big deals	RE
04/09/14	Roche : rules out mega deals, open to smaller ones - paper	RE
28/08/14	Biogen Idec : InterMune drug may offer big upside to Roche if aimed at liver	RE
26/08/14	Burger King Worldwide : S&P 500 sets record high but fails to hold 2,000 mark	RE
25/08/14	CHUGAI PHARMACEUTICAL : Roche to buy U.S. biotech firm InterMune for $8.3 billion	RE
20/03/14	Horizon Pharma Inc : With eye on tax rates, Horizon Pharma buys Ireland's Vidara	RE
07/06/13	NVIDIA Corporation : SAC insider-trading probe could last years	RE
21/03/13	Weight Watchers International, Inc. : SAC Capital up 4 percent this year as probe continues	RE
16/03/13	Morgan Stanley : Cohen's SAC to pay $616 million in SEC insider trade settlement	RE
28/12/12	InterMune, Inc. : Blackstone seen sticking with SAC despite insider trading probe	RE
20/12/12	Weight Watchers International, Inc. : SAC Capital's top consumer trader draws U.S. scrutiny	RE
08/12/12	Elan Corporation, plc : Exclusive: U.S. authorities probe SAC for Weight Watchers - sources	RE
24/07/12	InterMune, Inc. : InterMune posts lower-than-expected revenue	RE

02/10/14	InterMune : Announces Effective Date of Make Whole Fundamental Change and Offer to Purchase to Holders of 2.50% Senior Convertible Notes Due 2018	PU
20/09/14	InterMune : Reports Memorandum of Understanding in Connection with Consolidated Delaware Action	PR
05/09/14	InterMune : Announces Anticipated Fundamental Change for 5.00% Convertible Senior Notes Due 2015	PR
28/08/14	InterMune : Stockholders Encouraged to Contact Securities Law Firm about Takeover	PR
28/08/14	INTERMUNE : SHAREHOLDER ALERT – InterMune, Inc.: The Law Offices of Vincent Wong Investigates the Sale of InterMune, Inc. to Roche Holding AG	BU

04/09/14	Roche : exclut une mega-fusion, ouvert à de plus petits rachats
26/08/14	Wall Street finit dans le vert, le S&P passe un cap
25/08/14	Burger King Worldwide : Wall Street ouvre en hausse sur un nouveau record du S&P
25/08/14	Wall Street ouvre en hausse avec les M&A et l'Europe
25/08/14	Apple : USA-Les valeurs à suivre à Wall Street

Manager	Title	Age	Since
Edward Harrington CEO	Chief Executive Officer	-	-
Marianne T. Armstrong CTO	Chief Tech/Sci/R&D Officer	71	01/04/2002
Carla Fiankan LAW	General Counsel	-	01/08/2011

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LONZA GROUP AG	-1.40%	+0.12%	-14.73%	-12.58%	43.68B
REVOLUTION MEDICINES, INC.	+3.50%	-4.15%	+265.85%	+484.30%	30.65B
IQVIA HOLDINGS INC.	-0.61%	-3.11%	+14.00%	-12.36%	30.4B
BEONE MEDICINES AG	-1.27%	-7.02%	-0.82%	+20.47%	29.31B
CELLTRION, INC.	-0.66%	-5.84%	+7.59%	+12.76%	24.2B
MEDPACE HOLDINGS, INC.	+2.01%	+3.57%	+57.15%	+128.55%	13.3B
EUROFINS SCIENTIFIC SE	-1.65%	-1.08%	+7.92%	+7.56%	13.21B
ASCENDIS PHARMA A/S	+2.77%	-1.48%	-	-	13.03B
IONIS PHARMACEUTICALS, INC.	+0.68%	-1.74%	+103.98%	+81.60%	12.12B
Average	+0.37%	-1.64%	+55.12%	+88.79%	23.32B
Weighted average by Cap.	+0.11%	-1.65%	+51.89%	+89.54%